Inhibition of myocardial beta-adrenergic receptor (beta AR) desensitization via gene therapy concomitantly with beta AR blockade results in decreased beta AR kinase (beta ARK1) expression after infarction
Publication
, Conference
White, DC; Tevaearal, HT; Emani, SM; Hata, JA; Shah, AS; Glower, DD; Koch, WJ
Published in: CIRCULATION
October 31, 2000
Duke Scholars
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
October 31, 2000
Volume
102
Issue
18
Start / End Page
165 / 165
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
White, D. C., Tevaearal, H. T., Emani, S. M., Hata, J. A., Shah, A. S., Glower, D. D., & Koch, W. J. (2000). Inhibition of myocardial beta-adrenergic receptor (beta AR) desensitization via gene therapy concomitantly with beta AR blockade results in decreased beta AR kinase (beta ARK1) expression after infarction. In CIRCULATION (Vol. 102, pp. 165–165). LIPPINCOTT WILLIAMS & WILKINS.
White, D. C., H. T. Tevaearal, S. M. Emani, J. A. Hata, A. S. Shah, D. D. Glower, and W. J. Koch. “Inhibition of myocardial beta-adrenergic receptor (beta AR) desensitization via gene therapy concomitantly with beta AR blockade results in decreased beta AR kinase (beta ARK1) expression after infarction.” In CIRCULATION, 102:165–165. LIPPINCOTT WILLIAMS & WILKINS, 2000.
White DC, Tevaearal HT, Emani SM, Hata JA, Shah AS, Glower DD, et al. Inhibition of myocardial beta-adrenergic receptor (beta AR) desensitization via gene therapy concomitantly with beta AR blockade results in decreased beta AR kinase (beta ARK1) expression after infarction. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2000. p. 165–165.
White, D. C., et al. “Inhibition of myocardial beta-adrenergic receptor (beta AR) desensitization via gene therapy concomitantly with beta AR blockade results in decreased beta AR kinase (beta ARK1) expression after infarction.” CIRCULATION, vol. 102, no. 18, LIPPINCOTT WILLIAMS & WILKINS, 2000, pp. 165–165.
White DC, Tevaearal HT, Emani SM, Hata JA, Shah AS, Glower DD, Koch WJ. Inhibition of myocardial beta-adrenergic receptor (beta AR) desensitization via gene therapy concomitantly with beta AR blockade results in decreased beta AR kinase (beta ARK1) expression after infarction. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2000. p. 165–165.
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
October 31, 2000
Volume
102
Issue
18
Start / End Page
165 / 165
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology